PATIENT SELECTION: OCD DEEP BRAIN STIMULATION
Best results are achieved when the patient and caregiver are fully informed about the therapy risks and probable benefits, surgical procedures, follow-up requirements, and self-care responsibilities.
Reclaim™ DBS Therapy for OCD* may be considered for patients who meet the following criteria:
Use extreme care with lead implantation in patients with a heightened risk of intracranial hemorrhage. Physicians should consider underlying factors, such as previous neurological injury or prescribed medications (anticoagulants), that may predispose a patient to the risk of bleeding.
Physicians should be aware that the risks associated with initial surgery may increase with clinical conditions such as:
To help ensure maximum benefits from the neurostimulation system, long-term, post-surgical management of patients is recommended.
Stimulation parameters should be adjusted such that maximal symptom improvement is achieved with minimal side effects. High parameter values may indicate a system problem or less than optimal lead placement. Patients should be informed of the risks of higher stimulation parameters, which may result in possible excessive charge density. Refer to the Information for Prescribers Addendum for OCD for more information about excessive charge density.
Humanitarian Device: Authorized by Federal (U.S.A.) law for use as an adjunct to medications and as an alternative to anterior capsulotomy for treatment of chronic, severe, treatment-resistant obsessive-compulsive disorder (OCD) in adult patients who have failed at least three selective serotonin reuptake inhibitors (SSRIs). The effectiveness of this device for this use has not been demonstrated.